Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc." Results 61 - 80 of 292
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Oct 2018, 5:00 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), an increasing number of expert witnesses have been challenged by way of a Daubert motion. [read post]
9 Oct 2018, 5:00 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), there are several factors that should be considered by a court when determining the admissibility of expert testimony. [read post]
19 Jun 2018, 6:00 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), guides federal court analysis in determining admissibility of expert testimony. [read post]
12 Apr 2018, 6:00 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc. 509 U.S. 579 (1993), which enumerates the factors a court should consider when admitting expert testimony, along with its progeny, also fails to address what exactly “reasonable degree of certainty” means. [read post]
10 Apr 2018, 6:00 am by TEI Expert
Once the computer simulation is broken into these two parts, the analysis can be evaluated like any other analysis using Rule 702,[2] Daubert,[3] or the applicable law in the jurisdiction. [read post]
13 Mar 2018, 6:00 am by Christine Funk
Fleetwood Homes of Pennsylvania, Inc., 878 A.2d 509 (Me. 2005) although more Daubert than Frye. [read post]
28 Feb 2018, 6:00 am by Victoria Negron
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) to conclude whether the expert possesses the requisite level of expertise and whether the testimony is both relevant and reliable. [read post]
28 Dec 2017, 2:18 pm by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
12 Dec 2017, 6:00 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) also increased the admissibility of expert witness testimony, as the decision adopted a more flexible reliability standard for admissibility then the previous long-held standard set forth in Frye v. [read post]
24 Oct 2017, 6:00 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), which is also codified in Rule 702 of the Federal Rules of Evidence. [read post]
21 Oct 2017, 9:00 am by W.F. Casey Ebsary, Jr.
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), General Electric Co. v. [read post]
19 Oct 2017, 6:00 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc. and its progeny established the governing standard for the admissibility of expert witness testimony in federal courts. [read post]